Caught unprepared, men sometimes suppress their carnal urges minutes before intercourse just because they forgot to pack--but soon that won't be a problem anymore.

Vasalgel, a long-acting and non-hormonal contraceptive, is now coming to change the game.

At present, men have two choices of contraceptives: the less friction, less-fun condom and the more fun, no baby-at-all vasectomy.

But they both have pitfalls. According to Indian Express, condoms have an 18 percent chance of pregnancy rate annually, but are effective in preventing sexually transmitted disease if used correctly.

On the other hand, vasectomy is more effective if you don't really want to have kids, but by the off chance you decide to have a baby, it might be too late.

Vasalgel presents a better alternative: a recent study showed that it is more effective than rubber and is less permanent than getting snipped.

When getting a vasectomy, the vas deferens--the duct that transfers sperm from the testes to the urethra--is cut. Vasalgel works in the same way, except the cutting part.

A study published in the journal Basic and Clinical Andrology worked to prove the effectiveness of Vasalgel in 12 mature male rabbits.

UPI reported that the rabbits were treated with two formulations of Vasagel: one being pure styrene maleic acid (SMA) and the other a mix of 80 percent SMA and 20 percent anhydride.

Researchers discovered that both formulations of Vasagel were effective in the rabbits.

Sperm was not detected in 11 rabbits after being injected. One rabbit had a small quantity of sperm in the early stages, but eventually became azoospermic--so, no sperm count for that as well.

According to the press release of Parsemus Foundation, the maker of Vasalgel, the materials in the product will form a hydrogel that allows the water-soluble to pass through, except the sperm.

The best part of Vasalgel, except for the more friction and less pain, is that it is reversible.

If by any chance you decide to reproduce, the hydrogel can be flushed out of the vas deferens with another injection.

At present, Vasalgel is being developed as "social venture," which means that once it is developed, it will be available for everyone at an affordable price. Right now, Parsemus Foundation still needs financial backers for the development.